Brevetti EPO No.3255043 2021.01.20
Brevetti EPO
(10) Registration Number and Date
2021000173 2021.03.24
Status
Expired
(180) Expiration Date
(20) Filing Number and Date
SM /T/2021/000173 2012.07.10
(40) Publication Number and Date
SM /T/2021/000173 2021.03.24
(30) Priority Details
US 201161506737 P
2011.07.12
(71/73) Applicant
(72) Inventor
(IT) WILLIAMS, Andrew, John : AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, GB
(IT) LANGER, Thomas : AstraZeneca Charter Way, Macclesfield, Cheshire SK10 2NA, GB
(IT) STEVEN, Alan, Robert : AstraZeneca Charter Way, Macclesfield, Cheshire SK10 2NA, GB
(IT) WALTERS, Iain, Alastair, Stewart : C/o AstraZeneca Intellectual Property, AstraZeneca R&D AlderleyAlderley Park, Macclesfield, Cheshire SK10 4TG, GB
(IT) TOMLIN, Paula, Margaret : AstraZeneca Charter Way, Macclesfield, Cheshire SK10 2NA, GB
(IT) EBDEN, Mark, Richard : C/o AstraZeneca Intellectual Property, AstraZeneca R&D AlderleyAlderley Park, Macclesfield, Cheshire SK10 4TG, GB
(74) Representative Name
(IT) BUSCA, Andrea : Strada Caiese, 30, 47891 Dogana RSM, SM
(54) Title
(IT) N-(6-((2R,3S)-3,4-DIIDROSSIBUTAN-2-ILOSSI)-2-(4-FLUOROBENZILTIO)PIRIMIDIN-4-IL)-3-METILAZETIDIN-1-SOLFONAMMIDE COME MODULATORE DI RECETTORI DI CHEMOCHINE
(EN) N-(6-((2R,3S)-3,4-DIHYDROXYBUTAN-2-YLOXY)-2-(4-FLUOROBENZYLTHIO)PYRIMIDIN-4-YL)-3- METHYLAZETIDINE-1-SULFONAMIDE AS CHEMOKINE RECEPTOR MODULATOR
(57) Abstract
(58) Citations